May 11, 2011

Research on Cells Vulnerable to Alzheimer’s May Lead to New Treatments

“Dr. Greengard’s research has the potential to completely alter how we identify and treat Alzheimer’s disease,” Tim Armour, president and CEO of Cure Alzheimer’s Fund...
Alzheimer's Reading Room

“The Cure Alzheimer’s Fund grant comes at a time when our research is on the verge of making important breakthroughs,” said Dr. Greengard. “We are very grateful for their adamant support and recognition of the importance of research to better understand Alzheimer’s disease.”


Cure Alzheimer’s Fund Awards Grant to The Rockefeller University

Nobel laureate Paul Greengard, a Rockefeller University professor has been awarded a $100,000 grant by Cure Alzheimer’s Fund to continue his groundbreaking research on Alzheimer’s disease, the most common cause of dementia in the elderly that currently affects more than 5 million Americans and their families.

Paul Greengard, Ph.D., will use the grant to continue his studies on identifying brains cells that are vulnerable to Alzheimer’s. His studies could lead to the development of protective drugs targeted at those specific cells.

“Dr. Greengard’s research has the potential to completely alter how we identify and treat Alzheimer’s disease,” said Tim Armour, president and CEO of Cure Alzheimer’s Fund. “His lab’s research is another step toward relieving the suffering of millions of people and their families living with this devastating disease.”

Since 1983, Dr. Greengard has been a Vincent Astor Professor and the head of The Rockefeller University’s Laboratory of Molecular and Cellular Neuroscience. He is the director of the Fisher Center for Alzheimer’s Research at Rockefeller University. He has been recognized multiple times for his research, and was awarded the Nobel Prize in Physiology or Medicine in 2000.

Through the grant, Dr. Greengard will be studying mice infected with Alzheimer’s to find commonalities between the genes in the damaged regions of their brains. One of the several goals of the research is to study the genes that help to develop brain cells, some of which are susceptible to Alzheimer’s versus others that are resistant. These comparisons will yield lists of vulnerability genes that could potentially explain how vulnerable cells are vulnerable, or how resistance genes protect resistant cells from the pathology.

“The Cure Alzheimer’s Fund grant comes at a time when our research is on the verge of making important breakthroughs,” said Dr. Greengard. “We are very grateful for their adamant support and recognition of the importance of research to better understand Alzheimer’s disease.”

Over the past ten years the federal government’s investment in Alzheimer’s research and education has decreased. Since its inception in 2004, Cure Alzheimer’s Fund has invested more than $17 million directly into research.

Cure Alzheimer’s Fund has no endowment and no financial or intellectual property interest in the research funded, and will make known the results of all funded research as soon as possible.

“The groundbreaking work of Dr. Greengard and his team is a very encouraging step forward in Alzheimer’s research,” said Armour. “Research is where it all starts, and Cure Alzheimer’s Fund remains committed to funding researchers like Dr. Greengard who could bring us one step closer to our goal of finding a cure.”

About Cure Alzheimer’s Fund

Cure Alzheimer’s Fund is a 501c3 public charity whose mission is to fund research with the highest probability of slowing, stopping or reversing Alzheimer’s disease.

Cure Alzheimer’s Fund is characterized by a venture approach to philanthropy, which targets funding to specific research objectives. All expenses and overhead is paid for by its founders and all contributions go directly to research. The foundation has no financial of intellectual property interest in the research funded, and will make known the results of all funded research as soon as possible.

Cure Alzheimer’s Fund is a national organization with offices in Boston and Pittsburgh. For more information, visit www.curealzfund.org.

About The Rockefeller University

The Rockefeller University is a world-renowned center for research and graduate education in the biomedical sciences, chemistry, bioinformatics and physics. The university’s 73 laboratories conduct both clinical and basic research and study a diverse range of biological and biomedical problems with the mission of improving the understanding of life for the benefit of humanity. Since the institution’s founding in 1901, 23 Nobel Prize winners have been associated with the university.




Subscribe to the Alzheimer's Reading Room
Enter Your Email Address
More Insight and Advice for Caregivers


Bob DeMarco is the Founder of the Alzheimer's Reading Room and an Alzheimer's caregiver. The blog contains more than 2,680 articles with more than 512,100 links on the Internet. Bob lives in Delray Beach, FL.

The Alzheimer’s Action Plan: The Experts’ Guide to the Best Diag­no­sis and Treat­ment for Mem­ory Prob­lems   The 36-Hour Day A Family Guide to Caring for People with Alzheimer Disease


Original content Bob DeMarco, the Alzheimer's Reading Room